ANTINEOPLASTISCHE MITTEL
| ALKYLIERENDE MITTEL | ||
|---|---|---|
|
Endoxan®
|
L01AA01 | |
| ANTIMETABOLITEN | ||
|---|---|---|
|
Evoltra®
|
L01BB06 | |
|
Verrumal®, Verrucutan®, Actikerall®; Syn: FU; weiterer ATC-Code: D11AF55
|
L01BC52 | |
|
GEMCI-cell®, Gemedac®
|
L01BC05 | |
|
Puri-Nethol®, Xaluprine®; Syn: 6-Mercaptopurin
|
L01BB02 | |
|
Atriance®
|
L01BB07 | |
|
Lanvis, Thioguanin
|
L01BB03 | |
| PFLANZLICHE ALKALOIDE UND ANDERE NATÜRLICHE MITTEL | ||
|---|---|---|
|
Taxotere®, Doce NC®
|
L01CD02 | |
|
Riboirino®, Onivyde®
|
L01CE02 | |
| ANDERE ANTINEOPLASTISCHE MITTEL | ||
|---|---|---|
|
Velcade®
|
L01XG01 | |
|
Siklos®, Xromi®
|
L01XX05 | |
|
Natulan®
|
L01XB01 | |
|
Kymriah®
|
L01XL04 | |
|
Vesanoid®
|
L01XF01 | |
| PROTEINKINASE-INHIBITOREN | ||
|---|---|---|
|
Sprycel®
|
L01EA02 | |
|
Rozlytrek®
|
L01EX14 | |
|
Glivec®, Imanivec®
|
L01EA01 | |
|
Vitrakvi®
|
L01EX12 | |
|
Tasigna®
|
L01EA03 | |
| MONOKLONALE ANTIKÖRPER UND ANTIKÖRPER-WIRKSTOFF-KONJUGATE | ||
|---|---|---|
|
Qarziba®
|
L01FX06 | |
|
Keytruda®
|
L01FF02 | |
|
MabThera®, Blitzima®, Ritemvia®, Rixathon®, Riximyo®, Truxima®, Ruxience®
|
L01FA01 | |
